Association of α1-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis

Thorax

Volumn 56, Issue 1, 2001, Pages 53-58

  Mahadeva, R ^a   Sharples, L ^b   Ross Russell, R I ^c   Webb, A K ^d   Bilton, D ^e   Lomas, D A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d WYTHENSHAWE HOSPITAL   (United Kingdom)

^e PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

1 antichymotrypsin; 1 antitrypsin; Cystic fibrosis

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; SIGNAL PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; THORAX RADIOGRAPHY;

ADULT; ALPHA 1-ANTICHYMOTRYPSIN; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; LUNG DISEASES; MALE; MULTIVARIATE ANALYSIS; PROTEIN SORTING SIGNALS;

EID: 0035153395     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.1.53     Document Type: Article

References (34)

1. The relation between genotype and phenotype in patients with cystic fibrosis: Analysis of the most common mutation ΔF508
2. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis
3. Lysosomal enzymes and proteinase inhibitors in the sputum of patients with cystic fibrosis
4. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: Effect of antimicrobial treatment against Pseudomonas aeruginosa
5. 1-antitrypsin deficiency alleles and the Taq I G→A allele in cystic fibrosis lung disease
6. Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease
7. 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508
8. 1-antichymotrypsin
9. 1-antichymotrypsin mRNA
10. 1-antichymotrypsin: Interaction with chymotrypsin like proteinases
11. Enhancement by alpha-1-antichymotrypsin of antibody response in vivo
12. Inhibition of human natural cytotoxicity by macromolecular antiproteases
13. 1-antichymotrypsin deficiency
14. 1-antichymotrypsin
15. 1-antichymotrypsin is associated with chronic "cryptogenic" liver disease
16. 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease
17. 1-antichymotrypsin allele associated with familial obstructive lung disease
18. 1-antichymotrypsin polymorphism
19. The chest radiograph in cystic fibrosis: A new scoring system compared with the Chrispin-Norman and Brasfield scores
20. Sequential changes of plasma proteins after surgical trauma
21. The relative merits of acute phase proteins in the recognition of inflammatory conditions
22. Structure, function, and control of neutrophil proteinases
23. Antibiotic proteins of human neutrophils
24. Effect of combined human neutrophil cathepsin-G and elastase on induction of secretory-cell metaplasia and emphysema in hamsters, with in vitro observations on elastolysis by these enzymes
25. The elastolytic activity of cathepsin G: An ex vivo study with dermal elastin
26. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells
27. The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin
28. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria
29. 1-antichymotrypsin. Sites of cleavage and generation of chemotactic activity
30. 1-antichymotrypsin-cathepsin G complexes. Evidence for the involvement of interleukin-6
31. Evidence for a crucial role of neutrophil-derived serine proteases in the inactivation of interleukin-6 at sites of inflammation
32. Elastase from polymorphonuclear leucocytes: A regulatory enzyme in immune complex disease
33. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease